Trial Profile
A 6-Week Multi-center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/benazepril (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual initiation date (December 2004) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health),